1497400-26-6
1497400-26-6
Chemical Structure
Indusatumab
Synonym(s): 5F9 Monoclonal antibody; TAK-164 Antibody
- CAS No.: 1497400-26-6
- Formula:N/A
- Molecular Weight:(145.206 kDa)
SMILES: [Indusatumab]
Biological Activity: Indusatumab (5F9 Monoclonal antibody) is a monoclonal antibody against human GUCY2C (Guanylate cyclase 2C). Indusatumab fails to bind to granulocytes or erythrocytes. Indusatumab can be used to synthesize ADCs, such as Indusatumab vedotin (HY-P99662). Indusatumab can be used in cancer research[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Indusatumab | ≥99.0% | Indusatumab (5F9 Monoclonal antibody) is a monoclonal antibody against human GUCY2C (Guanylate cyclase 2C). Indusatumab fails to bind to granulocytes or erythrocytes. Indusatumab can be used to synthesize ADCs, such as Indusatumab vedotin (HY-P99662). Indusatumab can be used in cancer research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. e Goeij BE, et al. New developments for antibody-drug conjugate-based therapeutic approaches. Curr Opin Immunol. 2016 Jun;40:14-23. [Content Brief]
- [2]. Khazaeli MB, et al. Development and characterization of a monoclonal antibody to human embryonal carcinoma. J Urol. 1987 Jun;137(6):1295-9. [Content Brief]
